title: Protein composition of the hepatitis B virus e antigen in the natural course of disease and following interferon therapy.
abstract: The protein composition of hepatitis B virus (HBV) e antigen (HBeAg) in serum was analyzed for 63 viremic patients with chronic HBV and found to consist of polypeptides with molecular masses of 16, 18, and 20 kDa (P16e, P18e, and P20e, respectively). Several experiments demonstrated their viral nature and HBeAg specificity and that P16e occurs either in free soluble form or as aggregates or immunocomplexes, while P18e and P20e occur essentially as immunocomplexes. Of 63 patients, 45 (71%) had P16e, P18e, and P20e, and the remaining 18 (29%) had only P16e. During the natural history of the disease, spontaneous clearance of HBV DNA and HBeAg took place only in six of nine (67%) patients with the three HBe polypeptides but in none of the five patients having P16e alone (P less than 0.05). Similarly, 22 of 23 (96%) patients responding to interferon therapy had P16e, P18e, and P20e, but these polypeptides occurred in only 14 of 26 (54%) nonresponder patients (P less than 0.001). Following the loss of HBV DNA and HBeAg, before the development of anti-HBe, the only HBe species detected were P18e and P20e, but these became no longer detectable after complete normalization of liver function tests. Therefore, persistence of P16e represents a failure to recover from HBV, and the appearance of HBe polypeptides P18e and P20e is associated with virus clearance and a favorable outcome of the disease.
authors.affiliation: Department of Gastroenterology, Fundación Jiménez Díaz, Madrid, Spain.
authors.forename: M L
authors.initials: ML
authors.lastname: Campillo
authors.forename: J A
authors.initials: JA
authors.lastname: Quiroga
authors.forename: J
authors.initials: J
authors.lastname: Bartolomé
authors.forename: G
authors.initials: G
authors.lastname: Moraleda
authors.forename: I
authors.initials: I
authors.lastname: Castillo
authors.forename: V
authors.initials: V
authors.lastname: Carreño
mesh_terms: D000293:Adolescent; D000328:Adult; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D006509:Hepatitis B / Q000276:immunology* / Q000628:therapy; D006513:Hepatitis B e Antigens / Q000032:analysis*; D006515:Hepatitis B virus / Q000235:genetics; D006801:Humans; D007372:Interferons / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D014764:Viral Proteins / Q000032:analysis*
chemical_list: D004279:DNA, Viral; D006513:Hepatitis B e Antigens; D014764:Viral Proteins; D007372:Interferons